{
  "id": 15220022,
  "title": "I Just Invested $4,600 Across 3 Top Dividend Stocks. Here’s What I’m Loading Up on Right Now.",
  "url": "https://urgent.news/2026/10/17/i-just-invested-4-600-across-3-top-dividend-stocks-heres-what-im",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-17T15:00:02.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/17/i-just-invested-usd4-600-across-3-top-dividend-stocks-here-s-what-i-m-loading-up-on-right-now/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Over the past year, the stock market has shown signs of approaching a near-term top. The CAPE ratio is at its second-highest level in history, while margin debt has increased significantly. Inflation remains high, prompting the Federal Reserve to raise interest rates for the first time in three years. These factors have contributed to a shift in my investment strategy, aiming for a more defensive posture. I sold off some lower conviction holdings and redirected some of the proceeds into high-quality dividend stocks.\n\nAbbott Laboratories (ABT) has been a stellar dividend growth stock, increasing its dividend payment for 54 consecutive years, making it a Dividend King. The healthcare giant has grown its dividend by 70% since 2020, currently offering a 2.4% yield. Abbott has shown resilience with a nearly 10% compound annual growth in earnings per share over the last decade, driven by organic growth and acquisitions. With historically high cash flows and an attractive valuation, I invested $1,000 in Abbott stock.\n\nProcter & Gamble (PG) shares many durable features, with a portfolio of consumer brands like Febreze, Pampers, and Tide. The company has delivered 70 straight years of dividend increases, including a 4% raise in early 2026. PG's current valuation is at a low point, and it offers a nearly 2.8% yield. With a target for long-term growth and a high-yielding dividend, I invested over $2,000 in Procter & Gamble stock.\n\nPaychex (PAYX) is a leading provider of HR solutions, generating very durable cash flow. The company has increased its dividend by 10% this year, its fifth consecutive double-digit increase. Paychex's strong growth in revenue and adjusted earnings per share over the last five years, coupled with a high-yielding 4.3% dividend, led to my investment of nearly $1,600 in the business services company. Abbott, Procter & Gamble, and Paychex provide strong defensive characteristics, with durable earnings backing their high-yielding dividends. This makes them ideal stock choices as the market may be entering a more volatile period. These three stocks are essential to my portfolio as they offer potential for less volatility while still delivering attractive total returns in the long term.",
  "summary": "These companies pay durable and growing dividends.",
  "key_points": [
    "$4,600 invested in Abbott Laboratories, Procter & Gamble, and Paychex",
    "Abbott Laboratories (ABT) is a Dividend King with 54 consecutive years of dividend growth",
    "Procter & Gamble (PG) offers a 2.8% yield and is at a low point in valuation"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "I Just Invested $4,600 Across 3 Top Dividend Stocks. Here’s What I’m Loading Up on Right Now.",
        "url": "https://urgent.news/2026/10/17/i-just-invested-4-600-across-3-top-dividend-stocks-heres-what-im-15228243",
        "published": "2026-10-17T15:20:02.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}